
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway
Manman Guo, Zhongda Wang, Jinya Dai, et al.
Phytomedicine (2022) Vol. 112, pp. 154587-154587
Closed Access | Times Cited: 18
Manman Guo, Zhongda Wang, Jinya Dai, et al.
Phytomedicine (2022) Vol. 112, pp. 154587-154587
Closed Access | Times Cited: 18
Showing 18 citing articles:
Non-alcoholic fatty liver disease combined with rheumatoid arthritis exacerbates liver fibrosis by stimulating co-localization of PTRF and TLR4 in rats
Shengpeng Zhang, Peng Zhu, Jianan Yuan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 27
Shengpeng Zhang, Peng Zhu, Jianan Yuan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 27
Licorice: comprehensive review of its chemical composition, pharmacodynamics, and medicinal value
L. T. P. Dang, Yajing Jin, Ye Yuan, et al.
Acupuncture and Herbal Medicine (2024)
Open Access | Times Cited: 5
L. T. P. Dang, Yajing Jin, Ye Yuan, et al.
Acupuncture and Herbal Medicine (2024)
Open Access | Times Cited: 5
Naturally Occurring and Artificial Nonnutritive Sweeteners: Potential Impacts on Metabolic Diseases
Yuzhuo Wang, Ligen Lin
eFood (2025) Vol. 6, Iss. 1
Open Access
Yuzhuo Wang, Ligen Lin
eFood (2025) Vol. 6, Iss. 1
Open Access
Treatment of Liver Fibrosis with Chinese Medicines and Extracts: A Review
Xuewen Tian, L. Wang, Yang Liu, et al.
Natural Product Communications (2025) Vol. 20, Iss. 1
Open Access
Xuewen Tian, L. Wang, Yang Liu, et al.
Natural Product Communications (2025) Vol. 20, Iss. 1
Open Access
Factors Influencing Liver Cirrhosis Progression in Wilson's Disease Patients: A Retrospective Cohort Study Over 5 Years
Jieru Peng, Lu Zhang, Yao Dong, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Jieru Peng, Lu Zhang, Yao Dong, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Glycyrrhizic acid ameliorates hepatic fibrosis by inhibiting oxidative stress via AKR7A2
Qixin Wang, Tianming Lu, Ping Song, et al.
Phytomedicine (2024) Vol. 133, pp. 155878-155878
Closed Access | Times Cited: 4
Qixin Wang, Tianming Lu, Ping Song, et al.
Phytomedicine (2024) Vol. 133, pp. 155878-155878
Closed Access | Times Cited: 4
Neutrophil-Based Bionic Delivery System Breaks Through the Capillary Barrier of Liver Sinusoidal Endothelial Cells and Inhibits the Activation of Hepatic Stellate Cells
Dan Sun, Xiao Du, Xinyu Cao, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 2043-2057
Closed Access | Times Cited: 3
Dan Sun, Xiao Du, Xinyu Cao, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 2043-2057
Closed Access | Times Cited: 3
Jiawei Taohe Chengqi Decoction attenuates CCl4 induced hepatic fibrosis by inhibiting HSCs activation via TGF-β1/CUGBP1 and IFN-γ/Smad7 pathway
Linmao Ye, Jiaxin Huang, Xiaofan Liang, et al.
Phytomedicine (2024) Vol. 133, pp. 155916-155916
Closed Access | Times Cited: 2
Linmao Ye, Jiaxin Huang, Xiaofan Liang, et al.
Phytomedicine (2024) Vol. 133, pp. 155916-155916
Closed Access | Times Cited: 2
Ergothioneine suppresses hepatic stellate cell activation via promoting Foxa3-dependent potentiation of the Hint1/Smad7 cascade and improves CCl4-induced liver fibrosis in mice
Guangwen Shu, Lei Xiao, Guangqiong Li, et al.
Food & Function (2023) Vol. 14, Iss. 23, pp. 10591-10604
Closed Access | Times Cited: 2
Guangwen Shu, Lei Xiao, Guangqiong Li, et al.
Food & Function (2023) Vol. 14, Iss. 23, pp. 10591-10604
Closed Access | Times Cited: 2
Progress in the diagnosis and treatment of graft fibrosis after liver transplantation
Youwei Zhao, Lijun Wang, Man Xie, et al.
Portal hypertension & cirrhosis (2024) Vol. 3, Iss. 1, pp. 22-30
Open Access
Youwei Zhao, Lijun Wang, Man Xie, et al.
Portal hypertension & cirrhosis (2024) Vol. 3, Iss. 1, pp. 22-30
Open Access
Transcriptomic analysis reveals pharmacological mechanisms mediating efficacy of Yangyinghuoxue Decoction in CCl4-induced hepatic fibrosis in rats
Yan-Ming Bai, Shuang Liang, Yanhao Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Yan-Ming Bai, Shuang Liang, Yanhao Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Licoricesaponin G2 ameliorates bleomycin-induced pulmonary fibrosis via targeting TNF-α signaling pathway and inhibiting the epithelial-mesenchymal transition
Jing Ma, Lu Ding, Xiaoyu Zang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Jing Ma, Lu Ding, Xiaoyu Zang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
The therapeutic potential of glycyrrhizic acid and its metabolites in neurodegenerative diseases: evidence from animal models
Xiansi Zeng, Zixuan Sheng, Yuqian Zhang, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177098-177098
Closed Access
Xiansi Zeng, Zixuan Sheng, Yuqian Zhang, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177098-177098
Closed Access
Congenital intrahepatic portosystemic shunt in 27 children: an experience and treatment strategy of a single centre in China
Jinshan Zhang
Frontiers in Pediatrics (2024) Vol. 12
Open Access
Jinshan Zhang
Frontiers in Pediatrics (2024) Vol. 12
Open Access
Comprehensive Landscape of Matrix Metalloproteinases in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Zhongzheng Li, Huabin Zhao, Shenghui Wang, et al.
Deleted Journal (2023) Vol. 1, Iss. 1, pp. 1-14
Open Access | Times Cited: 1
Zhongzheng Li, Huabin Zhao, Shenghui Wang, et al.
Deleted Journal (2023) Vol. 1, Iss. 1, pp. 1-14
Open Access | Times Cited: 1
Picroside II prevents HSC activation and liver fibrosis in Mdr2-/- mice by polarizing M1 macrophages and balancing immune responses
Kexin Jia, Zhi Ma, Yinhao Zhang, et al.
Authorea (Authorea) (2023)
Open Access
Kexin Jia, Zhi Ma, Yinhao Zhang, et al.
Authorea (Authorea) (2023)
Open Access
Established Hepatic Stellate Cell Lines in Hepatology Research
Ralf Weiskirchen
Deleted Journal (2023) Vol. 1, Iss. 1, pp. 1-9
Open Access
Ralf Weiskirchen
Deleted Journal (2023) Vol. 1, Iss. 1, pp. 1-9
Open Access